Ca-A Cancer Journal for Clinicians : Impact Factor & More
eISSN: 1542-4863pISSN: 0007-9235
Share this on:
Key Metrics
CiteScore 
716.2
Impact Factor
>= 25
SNIP
173.93
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Ca-A Cancer Journal for Clinicians Journal Specifications
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1950 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Ca-A Cancer Journal for Clinicians ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Ca-A Cancer Journal for Clinicians
Radiotherapy followed by adjuvant temozolomide improves survival for patients with aggressive IDH-mutated anaplastic glioma.
- 1 Mar 2026
- CA: a cancer journal for clinicians
Ethical considerations of genetic and genomic testing in pediatric oncology: A narrative review.
- 1 Mar 2026
- CA: a cancer journal for clinicians
Title not available
- 1 Mar 2026
- CA: A Cancer Journal for Clinicians
Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study.
- 1 Mar 2026
- CA: a cancer journal for clinicians
Adding carboplatin to sequential taxane-anthracycline neoadjuvant chemotherapy shows improved event-free and overall survival benefits in premenopausal women with triple-negative breast cancer.
- 1 Mar 2026
- CA: a cancer journal for clinicians
Targeting tumor suppressor gene co-mutations in EGFR-mutant nonsmall cell lung cancer: How ACROSS2 sharpens the case for early intensification.
- 1 Mar 2026
- CA: a cancer journal for clinicians
Radiotherapy followed by adjuvant temozolomide improves survival for patients with aggressive IDH-mutated anaplastic glioma.
- 1 Mar 2026
- CA: a cancer journal for clinicians
Ethical considerations of genetic and genomic testing in pediatric oncology: A narrative review.
- 1 Mar 2026
- CA: a cancer journal for clinicians
Title not available
- 1 Mar 2026
- CA: A Cancer Journal for Clinicians
Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study.
- 1 Mar 2026
- CA: a cancer journal for clinicians
Adding carboplatin to sequential taxane-anthracycline neoadjuvant chemotherapy shows improved event-free and overall survival benefits in premenopausal women with triple-negative breast cancer.
- 1 Mar 2026
- CA: a cancer journal for clinicians
Targeting tumor suppressor gene co-mutations in EGFR-mutant nonsmall cell lung cancer: How ACROSS2 sharpens the case for early intensification.
- 1 Mar 2026
- CA: a cancer journal for clinicians
FAQs on Ca-A Cancer Journal for Clinicians
How long has Ca-A Cancer Journal for Clinicians been actively publishing? 
What is the publishing frequency of Ca-A Cancer Journal for Clinicians?
How many articles did Ca-A Cancer Journal for Clinicians publish last year?
What is the eISSN & pISSN for Ca-A Cancer Journal for Clinicians?
What is Citescore for Ca-A Cancer Journal for Clinicians?
What is SNIP score for Ca-A Cancer Journal for Clinicians?
Who is the publisher of Ca-A Cancer Journal for Clinicians?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations